Meeting
2020 ASCO Virtual Scientific Program
Investigating the tumor immune infiltrate for populations that predict immune-related adverse events (irAEs) in patients receiving PD-1 inhibitors.
Authors
Steven Michael Blum
Massachusetts General Hospital and Dana-Farber Cancer Institute, Boston, MA
Steven Michael Blum , Neal Smith , Moshe Sade-Feldman , Dennie T. Frederick , Russell William Jenkins , Justine Vanessa Cohen , Donald P. Lawrence , Meghan Mooradian , Christine Freedman , Riley Fadden , Krista M. Rubin , Sarah Richey , Keith Flaherty , Jennifer Ann Wargo , Nir Hacohen , Ryan J. Sullivan , Genevieve Marie Boland , Alexandra C Villani
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Immunotherapy
Track
Developmental Therapeutics—Immunotherapy
Sub Track
Tissue-Based Biomarkers
Citation
J Clin Oncol 38: 2020 (suppl; abstr 3116)
DOI
10.1200/JCO.2020.38.15_suppl.3116
Abstract #
3116
Poster Bd #
180
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Risk of immune-related adverse events (irAE) with immune checkpoint inhibitors (ICI) in patients (pts) with family history (FH) of autoimmune disease (AID).
First Author: Piyush Grover
Poster
2021 ASCO Annual Meeting
The use of cryoablation to overcome resistance to PD-1 blockade in unresectable melanoma.
First Author: Meghan Mooradian
Poster
2021 Genitourinary Cancers Symposium
Safety and efficacy outcomes in immune checkpoint inhibitor (ICI)-treated metastatic urothelial carcinoma (mUC) patients (pts) requiring treatment interruption (TI) due to immune-related adverse events (irAEs).
First Author: Amanda Nizam
Poster
2020 ASCO Virtual Scientific Program
Early response marker during pembrolizumab treatment in metastatic urothelial cancer: Temporal shift in peripheral CD4 T cells expressing chemokine receptors.
First Author: Maud Rijnders